costs, actual reimbursements, contribution margin, CMI, and rate of complication/comorbidities (CC) and major complication/comorbidities (MCC) assigned to each discharge were abstracted. Data were compared over time by standardizing Centers for Medicare and Medicaid Services (CMS) values for each DRG and using a CMS baserate reimbursement. Clinical documentation for each admission was reviewed by trained coding specialists to identify impacting diagnoses and potentially impactful missed diagnosis.
SS28.

Financial Implications of Coding Inaccuracies in Patients Undergoing Endovascular Abdominal Aortic Aneurysm Repair
Suniah S. Ayub, Salvatore T. Scali, David K. Bielick, Thomas S. Huber, Javairiah Fatima, Kristina A. Giles. University of Florida, Gainesville, Fla
Objectives: High graft costs for endovascular abdominal aortic aneurysm repair (EVAR) have resulted in small or negative margins between hospitalization cost and reimbursement. Hospitals obtain reimbursement based upon Medicare Severity-Diagnosis-Related Group (MS-DRG) coding to distinguish patient encounters with or without major comorbidity and/or complication (MCC). This study's objective was to evaluate coding accuracy and effect upon hospital cost for patients undergoing EVAR.
Methods: We identified 104 EVARs identified, including 94 "standard" (MS-DRG 238, n ¼ 88; MS-DRG 254, n ¼ 6) and 10 "complex" hospitalizations (MS-DRG 237, n ¼ 9; MS-DRG 253, n ¼ 1, MS-DRG 252, n ¼ 0; Table) .
Results: Upon review, 4% of patients were undercoded with MS-DRG of 238 assigned when the patients met MCC criteria for coding as 237. Hospitalizations coded with MS-DRG 253 and 254 were considered billing errors as well as MS-DRG 237 and 238 are more appropriate as "major cardiovascular procedures" (CMS.gov). This miscoding represented a total lost billing opportunity of $646,455. Mean length of stay in standard and complex hospitalizations were 3.0 6 1.5 vs 7.6 6 5.8 days (P < .001) and intensive care unit length of stay was 0.4 6 0.7 vs 2.4 6 3.1 days (P < .001). Postoperative complications occurred in 23% patients; however, not all met Centers for Medicare and Medicaid Services criteria as a MCC. Miscoded complexity was found to be due to postoperative events in all patients rather than missed comorbidities. Mean hospitalization costs for standard and complex patients was $28,863 6 $5621 vs $40,446 6 $13,096 (P < .001; Fig) . Conclusions: Our study reveals a large lost billing opportunity with miscoding of EVARs from 2010 to 2015, with errors in categorization of the procedure as well as miscoding of complexity. The revenue impact is potentially significant in this population and additional reviews of coding practices should be considered. Objectives: The aim of this study was to define the safety and effectiveness of a contrast-enhanced ultrasound (CEUS)-based follow-up as endovascular aortic repair (EVAR) surveillance model at a midterm period of 4 years.
Methods: At our tertiary referral center, EVAR surveillance was based on plain abdominal radiographs and duplex ultrasound imaging, with computed tomography angiography (CTA) reserved for any abnormalities or nondiagnostic imaging during the period 1999 to 2011 (group A). From 2012, CEUS imaging was started to be performed in case of presence of (1) any endoleak, (2) significant aneurysm expansion (sac growth >5 mm #6 months), and patients with (3) renal insufficiency (chronic kidney disease stage $3) or (4) iodine contrast allergy (group B).
Results: Included were 880 patients (mean age, 75.6 6 8.4 years; 824 men) who underwent EVAR between 1999 and 2015 and with a minimum of 1 year follow-up; of these, 619 patients were in group A (70%) and the remaining 261 in group B (30%). Median follow-up was 48 months (interquartile range, 24-84). During the study period 318 CEUS imaging studies were performed with zero related complications. Indications for CEUS were a ¼ 160 (50%), b ¼ 34 (11%), c ¼ 91 (29%), and d ¼ 33 (10%). CEUS was compared to CTA in the first 100 patients, and CEUS had 100% sensitivity and 100% specificity in classify endoleaks. Moreover, CTA misclassified two type II endoleaks (one as type I and one as type III). In all cases, CEUS was able to detect the presence and type of endoleak. Survival was 94.5% at 2 years, 80.6% at 4 years, 74.5% at 6 years, and 62.8% at 8 years. Six aneurysm-related deaths occurred, four (0.6%) in group A and two (0.7%) in group B (P ¼ .275). Freedom from endoleak was 86.4% at 2 years, 81% at 4 years, 79.3% at 6 years, and 73.2% at 8 years. Freedom from reintervention was 95.6% at 2 years, 94.1% at 4 years, 90.4% at 6 years, and 87.1% at 8 years. No differences in endoleak, reinterventions, and sac shrinkage rate were seen between the two groups at 4 years. A 4-year analysis of CTA usage allowed for a 90% reduction with the CEUS introduction.
Conclusions: The introduction of a CEUS-based protocol for EVAR follow-up was safe and effective and was comparable to the previous CTA-based protocol follow-up in a midterm period. Moreover, CEUS allowed for 90% reduction of CTA.
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SS30. Vascular Surgery Patients With Coronary Drug-Eluting Stents Have a Significantly Increased Risk of Perioperative MI Despite the Use of Appropriate Antiplatelet Medications
Caron Rockman, Thomas Maldonado, Glenn Jacobowitz, Yu Guo, Neal Cayne, Mikel Sadek, Jeffrey Berger. New York University, New York, NY Objectives: There are no universally accepted guidelines regarding patients who require noncardiac surgery following the placement of drugeluting stents (DES) in the coronary arteries. Delaying elective surgery and maintaining antiplatelet medications have been suggested to reduce the risk of perioperative cardiac complications. The objectives of this study were to evaluate factors predisposing towards perioperative myocardial infarction (MI) in a prospectively studied patient population undergoing open vascular surgery.
Methods: Data were prospectively collected and subsequently analyzed as part of an American Heart Association funded singleinstitution clinical trial designed to analyze factors predisposing towards thrombotic and hemorrhagic complications in patients undergoing open vascular surgery. Perioperative MI was diagnosed by electrocardiogram results, relevant symptoms, and troponin levels using American College of Cardiology/American Heart Association guidelines.
Results: A cohort of 125 patients (30.2% women) who underwent carotid endarterectomy or lower extremity bypass procedures was analyzed; of these, 42.6% had a history of coronary disease, 14.7% had a history of MI, 31% had diabetes, 86.8% had hyperlipidemia, and 91.5% had hypertension. Of the entire cohort, 17 (13.6%) had a prior coronary DES. The incidence of perioperative MI was significantly increased among DES patients compared to those without (23.5% vs 3.7%; P ¼ .01). In contrast, patients with bare metal stents did not have a significantly increased risk of perioperative MI. We examined preoperative medications and the timing of surgery, and none of these factors had a significant effect on the rate of perioperative MI. Of DES patients who sustained a perioperative MI: all had taken aspirin within 24 hours of surgery; 75% had taken clopidogrel within 24 hours of surgery; 75% had taken a statin within 24 hours of surgery; and all were treated with bblockers and an angiotensin-converting enzyme inhibitor. Half (50%) of the perioperative MIs in DES patients occurred after carotid endarterectomy, and 50% occurred following or lower extremity bypass. Half (50%) of the perioperative MIs in DES patients occurred in patients with a remote history of DES (>3 years prior), and 50% occurred in cases in which the DES was placed within 1 year prior to surgery.
Conclusions: Patients with coronary DES remain at significantly increased risk for perioperative MI following open vascular surgery, even several years following DES placement. While appropriate medical management of these patients is imperative, it appears that it does not eliminate the risk of perioperative cardiac complications. An appropriate riskto-benefit analysis must be performed in patients with prior DES who require open vascular surgery procedures to determine the appropriate individual course of treatment.
Author Disclosures: J. Berger: Nothing to disclose; N. Cayne: Nothing to disclose; Y. Guo: Nothing to disclose; G. Jacobowitz: Nothing to disclose; T. Maldonado: Nothing to disclose; C. Rockman: Nothing to disclose; M. Sadek: Nothing to disclose. Objectives: Endovascular reconstructions of the femoropopliteal artery (FPA) demonstrate high rates of failure. Poor durability of repair is often attributed to severe mechanical deformations that occur with limb flexion and inability of stent designs to accommodate these deformations. Stent-artery interactions associated with limb flexion-induced 
